港股異動 | 獲券商看好 特步國際(1368.HK)漲5%欲創新高
格隆匯5月24日丨特步國際(1368.HK)股價午後持續,現漲5.08%,現報7.44港元,逼近前歷史高點7.475港元,最新總市值195.07億港元;年內累計漲約95%。天風證券發佈對公司指,首次覆蓋,給予買入評級,目標價11.44港元,目標市值為300億港元。考慮到疫情影響,去年公司經營表現較為穩健總體上維持良好經營勢頭,隨着21年疫情得到控制以及居民消費水平恢復,增長潛力較大。預計公司2021至2023年總營收分別為89.99、101.01、114.91億元,對應淨利潤分別為6.71、8.05、9.66億元,對應PE分別為22x、19x、15x。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.